These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6754331)

  • 21. [Blood sugar, insulin, and blood lipid disorders after oral administration of glucose and medium-chain triglycerides in diabetics].
    Ferlito S; Lo Furno F; Munaò F; Lunetta M
    Minerva Dietol Gastroenterol; 1978; 24(1):33-42. PubMed ID: 740266
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of galactose and sugar substitutes on blood insulin levels in normal and obese individuals.
    Ambrus JL; Ambrus CM; Shields R; Mink IB; Cleveland C
    J Med; 1976; 7(6):429-38. PubMed ID: 796401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Transdermal administration of insulin in type II diabetics. Results of a clinical pilot study].
    Liedtke RK; Sorger M; Merk F; Vetter H
    Arzneimittelforschung; 1990 Aug; 40(8):884-6. PubMed ID: 2242080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin sensitivity of blood glucose versus insulin sensitivity of blood free fatty acids in normal, obese, and obese-diabetic subjects.
    Belfiore F; Iannello S; Camuto M; Fagone S; Cavaleri A
    Metabolism; 2001 May; 50(5):573-82. PubMed ID: 11319720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventive effects of a soy-based diet supplemented with stevioside on the development of the metabolic syndrome and type 2 diabetes in Zucker diabetic fatty rats.
    Dyrskog SE; Jeppesen PB; Colombo M; Abudula R; Hermansen K
    Metabolism; 2005 Sep; 54(9):1181-8. PubMed ID: 16125530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison between diabetics receiving a high or low daily insulin dosage.
    Asplin CM; Hartog M; Goldie DJ; Alberti KG; Smythe P; Binder C; Fabero OK
    Horm Metab Res; 1978 Sep; 10(5):365-9. PubMed ID: 568594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Administration of aspartame in non-insulin-dependent diabetics.
    Stern SB; Bleicher SJ; Flores A; Gombos G; Recitas D; Shu J
    J Toxicol Environ Health; 1976 Nov; 2(2):429-39. PubMed ID: 1011296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consumption of rapeseed honey leads to higher serum fructose levels compared with analogue glucose/fructose solutions.
    Münstedt K; Böhme M; Hauenschild A; Hrgovic I
    Eur J Clin Nutr; 2011 Jan; 65(1):77-80. PubMed ID: 20823899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of isomalt and sucrose by means of continuous indirect calorimetry.
    Thiébaud D; Jacot E; Schmitz H; Spengler M; Felber JP
    Metabolism; 1984 Sep; 33(9):808-13. PubMed ID: 6381959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic response to oral challenge of hydrogenated starch hydrolysate versus glucose in diabetes.
    Wheeler ML; Fineberg SE; Gibson R; Fineberg N
    Diabetes Care; 1990 Jul; 13(7):733-40. PubMed ID: 2201496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ceruletide and IRI and blood glucose levels in normal subjects and in diabetics: a controlled study.
    Pontiroli AE; Alberetto M; Vegeto G; Dossi G; De Paolis C; Conte D; Pozza G
    Horm Metab Res; 1982 Jun; 14(6):329-30. PubMed ID: 6749628
    [No Abstract]   [Full Text] [Related]  

  • 32. Carbohydrate metabolism and urinary excretion of calcium and oxalate after ingestion of polyol sweeteners.
    Nguyen NU; Dumoulin G; Henriet MT; Berthelay S; Regnard J
    J Clin Endocrinol Metab; 1993 Aug; 77(2):388-92. PubMed ID: 8345042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic response to lactitol and xylitol in healthy men.
    Natah SS; Hussien KR; Tuominen JA; Koivisto VA
    Am J Clin Nutr; 1997 Apr; 65(4):947-50. PubMed ID: 9094877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diurnal profiles of serum insulin, C-peptide and blood intermediary metabolites in insulin treated diabetics, their relationship to the control of diabetes and the role of endogenous insulin secretion.
    Asplin CM; Hartog M; Goldie DJ; Alberti KG; Binder C; Faber OK
    Q J Med; 1979 Apr; 48(190):343-60. PubMed ID: 574299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of oral administration of maltitol on plasma glucose, plasma sorbitol, and serum insulin levels in man.
    Secchi A; Pontiroli AE; Cammelli L; Bizzi A; Cini M; Pozza G
    Klin Wochenschr; 1986 Mar; 64(6):265-9. PubMed ID: 3520129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Free insulin, bound insulin, C-peptide and the metabolic control in juvenile onset diabetics: comparison of C-peptide secretors and non-secretors during 24 hours conventional insulin therapy.
    Gerbitz KD; Kemmler W; Edelmann A; Summer J; Mehnert H; Wieland OH
    Eur J Clin Invest; 1979 Dec; 9(6):475-83. PubMed ID: 119646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison between glucose and "toleran G50", with special reference to blood sugar, insulin and C-peptide levels].
    Ide H; Aikawa T; Oguma Y; Sakai H
    Horumon To Rinsho; 1977 Oct; 25(10):1161-3. PubMed ID: 589816
    [No Abstract]   [Full Text] [Related]  

  • 38. [What is has the artificial sweeteners in indication the food of our diabetics?].
    Demnati C; Ben Mami F; Fendi O; Gaigi I; Trimèche A; Trabelsi N; Dakhli S; Achour A
    Tunis Med; 2012 Mar; 90(3):238-41. PubMed ID: 22481196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naloxone modulates gustatory perception, but not insulin and C-peptide release, in sham-fed human subjects.
    Komorowski JM; Komorowska A
    Int J Obes; 1986; 10(2):83-9. PubMed ID: 3522452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of palatinose as a caloric sweetener for diabetic patients.
    Kawai K; Yoshikawa H; Murayama Y; Okuda Y; Yamashita K
    Horm Metab Res; 1989 Jun; 21(6):338-40. PubMed ID: 2673967
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.